Making Chemotherapy Toxicity Palatable by What You Put or Don’t on Dinner Plate

Watching what we eat and how much we eat may be an effective tool to manage the toxicity of chemotherapy drugs says this month's online article in the New England Journal of Medicine.

Oral Mucositis: an Underappreciated Problem in Cancer Care

How big is the problem?
25-30% of all cancer patients undergoing chemo suffer form oral mucositis, and almost all of the BMT patients.

Watchlist: Will nimotuzumab emerge as one of the best-in-class anti-EGFR MAB?

 Nimotuzumab (h-R3mAb, TheraCIM) is an EGFR targeting monoclonal antibody approved for glioma, malignant astrocytomes and squamous cell carcinoma of head and neck in several countries outside US.  Phase II/III studies for FDA approval are ongoing.

Reducing chemotoxicity - Herbs to the rescue!

"Herbal medicine reduces chemotherapy toxicity," this headline in the "highlights" section of the latest issue of Nature Reviews Drug Discovery, caught my attention.  This was the first time, I saw "herbs" casted in a positive light re: cancer care -- completely opposite to the establishment's stream-rolled opinion that herbs, generally speaking, interfere in unknown ways with current allopathic medications and medical care.